Actelion Ltd
Actelion Ltd., a leading biopharmaceutical company headquartered in Switzerland (CH), has established itself as a pioneer in the treatment of pulmonary arterial hypertension (PAH) and other rare diseases. Founded in 1997, Actelion has achieved significant milestones, including its acquisition by Johnson & Johnson in 2017, which further solidified its market position. The company focuses on innovative therapies, with core products such as Tracleer, Opsumit, and Uptravi, each designed to improve the quality of life for patients suffering from PAH. Actelion's commitment to research and development sets it apart, as it continually seeks to address unmet medical needs in the industry. With a strong presence in Europe, North America, and Asia, Actelion Ltd. remains a key player in the biopharmaceutical landscape, recognised for its contributions to advancing healthcare solutions.
DitchCarbon Score
How does Actelion Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Actelion Ltd's score of 45 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Actelion Ltd's reported carbon emissions
Actelion Ltd, headquartered in Switzerland (CH), currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the company is expected to align with industry standards and best practices regarding climate commitments. As the pharmaceutical sector increasingly focuses on sustainability, Actelion may be exploring strategies to address carbon emissions and enhance environmental responsibility in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Actelion Ltd is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
